Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: A role for age at disease onset?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 83, Issue 3, 2012, Pages 251-257

  Merola, Aristide ^a   Zibetti, Maurizio ^a   Artusi, Carlo Alberto ^a   Marchisio, Alice ^a   Ricchi, Valeria ^a   Rizzi, Laura ^a   Angrisano, Serena ^a   Arduino, Nichy ^a   Lanotte, Michele ^a   Rizzone, Mario ^a   Lopiano, Leonardo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CONSTIPATION; CONTROLLED STUDY; DEMENTIA; DISEASE DURATION; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; ONSET AGE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; UNIFIED PARKINSON DISEASE RATING SCALE; YOUNG ONSET PARKINSON DISEASE;

EID: 84857048260     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2011-300470     Document Type: Article

References (34)

1. Schrag A, Ben Shlomo Y, Brown R, et al. Young onset Parkinson's disease revisited clinical features, natural history, and mortality. Mov Disord 1998;13:885-94. (Pubitemid 28517664)
2. Calne SM, Kumar A. Young onset Parkinson's disease. Practical management of medical issues. Parkinsonism Relat Disord 2008;14:133-42. (Pubitemid 351726309)
3. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.
4. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 1990;40:1529-34. (Pubitemid 20351344)
5. Butterfield PG, Valanis BG, Spencer PS, et al. Environmental antecedents of youngonset Parkinson's disease. Neurology 2006;43:1150-8.
6. Otaka T, Oshima H, Katayama Y, et al. Impact of subthalamic nucleus stimulation on young-onset Parkinson's disease. Neuromodulation 2010;13:10-16.
7. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-83. (Pubitemid 34194412)
8. Russmann H, Ghika J, Villemure JG, et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 2004;63:1952-4. (Pubitemid 39532401)
9. Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, et al. Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov Disord 2007;22:1457-63. (Pubitemid 47280632)
10. Derost PP, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007;68:1345-55. (Pubitemid 46659085)
11. Umemura A, Oka Y, Okita K, et al. Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson's disease. Parkinsonism Relat Disord 2010;16:582-4.
12. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 2010;133:2664-76.
13. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34. (Pubitemid 37409709)
14. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-9. (Pubitemid 41407964)
15. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-86.
16. Schüpbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640-4. (Pubitemid 41697626)
17. Wider C, Pollo C, Bloch J, et al. Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord 2008;14:114-19. (Pubitemid 351735982)
18. Kempster PA, Williams DR, Selikhova M, et al. Patterns of levodopa response in Parkinson's disease: a clinico-pathological study. Brain 2007;130:2123-8. (Pubitemid 47236624)
19. Fahn S, Elton R. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, et al, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information, 1987;2:153-63.
20. Defer GL, Widner H, Marié RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-84. (Pubitemid 30011449)
21. Lanotte MM, Rizzone M, Bergamasco B, et al. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002;72:53-8. (Pubitemid 34073097)
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (IV-TR). Washington, DC: American Psychiatric Associatio, 2000.
23. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-304. (Pubitemid 44028288)
24. Piboolnurak P, Lang AE, Lozano AM, et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007;22:990-7. (Pubitemid 46999296)
25. St George RJ, Nutt JG, Burchiel KJ, et al. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 2010;75:1292-9.
26. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003;299:256-9. (Pubitemid 36131051)
27. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8. (Pubitemid 28207717)
28. Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding alphasynuclein in Parkinson's disease. Nat Genet 1998;18:106-8.
29. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-60. (Pubitemid 38661852)
30. Inzelberg R, Polyniki A. Are genetic and sporadic Parkinson's disease patients equally susceptible to develop dementia? J Neurol Sci 2010;289:23-6.
31. Breit S, Wächter T, Schmid-Bielenberg D, et al. Effective long-term subthalamic stimulation in PARK8 positive Parkinson's disease. J Neurol 2010;257:1205-7.
32. Lohmann E, Welter ML, Fraix V, et al. Are parkin patients particularly suited for deep-brain stimulation? Mov Disord 2008;23:740-3.
33. Gómez-Esteban JC, Lezcano E, Zarranz JJ, et al. Outcome of bilateral deep brain subthalamic stimulation in patients carrying the R1441G mutation in the LRRK2 dardarin gene. Neurosurgery 2008;62:857-62.
34. Moro E, Volkmann J, König IR, et al. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology 2008;70:1186-91. (Pubitemid 351482570)